2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy - Trial NCT06420388
Access comprehensive clinical trial information for NCT06420388 through Pure Global AI's free database. This phase not specified trial is sponsored by E-DA Hospital and is currently Recruiting. The study focuses on Surgery,Pain, Postoperative. Target enrollment is 400 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
E-DA Hospital
Timeline & Enrollment
N/A
May 01, 2023
Oct 01, 2024
Primary Outcome
Postoperative pain
Summary
The study is a randomized, double-blind, controlled trial evaluating the efficacy of 2%
 lidocaine gel in reducing postoperative pain and analgesic consumption after
 haemorrhoidectomy. 222 patients undergoing Ferguson haemorrhoidectomy will be randomly
 assigned to receive either 2% lidocaine gel or a non-anaesthetic lubricant gel control. Pain
 scores using a visual analog scale (VAS) will be assessed at 12 and 24 hours, and 2, 3, and 7
 days postoperatively. Analgesic consumption will also be measured.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06420388
Non-Device Trial